Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2017

01-09-2017 | Letter to the Editor

In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective study

Authors: Martin Cremer, Mark-Alexander Schwarzbich, Tilman Schöning, Katharina Lisenko, Anthony D. Ho, Mathias Witzens-Harig

Published in: Annals of Hematology | Issue 9/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
3.
Rizzieri DA, Johnson JL, Byrd JC et al (2014) Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10 002. Br J Haematol 165:102–111. doi:10.​1111/​bjh.​12736 CrossRefPubMedPubMedCentral
4.
5.
6.
Maramattom LV, Hari PN, Burns LJ et al (2013) Autologous and allogeneic transplantation for Burkitt lymphoma outcomes and changes in utilization: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 19:173–179. doi:10.​1016/​j.​bbmt.​2012.​11.​016 CrossRefPubMed
7.
Peniket AJ, Ruiz de Elvira MC, Taghipour G et al (2003) An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 31:667–678. doi:10.​1038/​sj.​bmt.​1703891 CrossRefPubMed
8.
9.
Awasthi A, Ayello J, Van de Ven C et al (2015) Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20+ rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia. Br J Haematol 171:763–775. doi:10.​1111/​bjh.​13764 CrossRefPubMed
Metadata
Title
In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective study
Authors
Martin Cremer
Mark-Alexander Schwarzbich
Tilman Schöning
Katharina Lisenko
Anthony D. Ho
Mathias Witzens-Harig
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-3044-4

Other articles of this Issue 9/2017

Annals of Hematology 9/2017 Go to the issue

Review Article

PD-1 signaling and inhibition in AML and MDS

Letter to the editor

Low-dose nivolumab-induced responses in acute lymphoblastic leukaemia relapse after allogeneic haematopoietic stem cell transplantation

Review Article

Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists

Letter to the Editor

Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)

Review Article

Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia

Letter to the Editor

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits